Less Surgery, Smarter Drugs: The Trials Rewriting Breast Cancer Care in 2025
Landmark trials from 2024 and 2025 are transforming breast cancer care by safely scaling back surgery while unleashing antibody-drug conjugates, ...
Landmark trials from 2024 and 2025 are transforming breast cancer care by safely scaling back surgery while unleashing antibody-drug conjugates, ...
A large real-world cohort study confirms that the Evans index, a simple ratio measured on routine brain scans, independently predicts ...
Researchers engineered an anti-C4d antibody that targets complement fragments left on tumor cells that survived antibody therapy, boosting complement-mediated killing ...
Chemists have designed nine 1,3,4-oxadiazole derivatives that inhibit breast cancer cells in vitro, with the lead compound R3 showing an ...
A new computational study shows that the plant flavonoid kaempferol and the chemotherapy drug docetaxel both bind strongly to the ...
New research shows that the p53 tumour suppressor system in breast cancer cells retains its dynamic, oscillation-like response even at ...
Researchers have unveiled TomoMamba, a two-stage AI framework that uses selective state-space models to propagate features across DBT slices, achieving ...
Computational simulations show that the citrus flavonoid hesperidin can be paired with technetium for imaging and rhenium for therapy, with ...
A new study of 131 women with benign, high-risk, and malignant breast disease finds that higher body mass index is ...
Researchers have built ProteinTalks, an AI virtual cell model trained on more than 38 million time-resolved protein measurements from perturbed ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine